Globe Life Key Executives
This section highlights Globe Life's key executives, including their titles and compensation details.
Find Contacts at Globe Life
(Showing 0 of )
Globe Life Earnings
This section highlights Globe Life's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
---|---|---|---|---|---|
Read Transcript | Q4 | 2024 | 2025-02-06 | N/A | N/A |
Read Transcript | Q3 | 2024 | 2024-10-24 | N/A | N/A |
Read Transcript | Q2 | 2024 | 2024-07-25 | N/A | N/A |
Read Transcript | Q1 | 2024 | 2024-04-23 | N/A | N/A |
Read Transcript | Q4 | 2023 | 2024-02-08 | N/A | N/A |
Read Transcript | Q3 | 2023 | 2023-10-26 | N/A | N/A |
Read Transcript | Q2 | 2023 | 2023-07-27 | N/A | N/A |
Read Transcript | Q1 | 2023 | 2023-05-05 | N/A | N/A |

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
$127.51
Stock Price
$10.69B
Market Cap
-
Employees
McKinney, TX
Location
Financial Statements
Access annual & quarterly financial statements for Globe Life, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Revenue | $5.78B | $5.45B | $5.21B | $5.11B | $4.74B |
Cost of Revenue | $- | $347.83M | $353.95M | $322.03M | $301.04M |
Gross Profit | $5.78B | $5.10B | $4.86B | $4.79B | $4.44B |
Gross Profit Ratio | 100.00% | 93.60% | 93.21% | 93.70% | 93.65% |
Research and Development Expenses | $- | $- | $- | $- | $- |
General and Administrative Expenses | $382.55M | $331.90M | $334.99M | $301.90M | $286.84M |
Selling and Marketing Expenses | $- | $- | $9.40M | $10.00M | $9.80M |
Selling General and Administrative Expenses | $382.55M | $331.90M | $334.99M | $301.90M | $286.84M |
Other Expenses | $5.40B | $5.12B | $-4.20B | $-4.50B | $-4.13B |
Operating Expenses | $5.78B | $5.45B | $-3.86B | $-4.20B | $-3.84B |
Cost and Expenses | $5.78B | $5.45B | $4.31B | $4.20B | $3.84B |
Interest Income | $- | $- | $90.39M | $83.49M | $86.70M |
Interest Expense | $127.09M | $102.32M | $90.39M | $83.49M | $86.70M |
Depreciation and Amortization | $- | $- | $21.00M | $20.00M | $17.00M |
EBITDA | $- | $- | $- | $1.02B | $- |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 17.82% | 18.90% |
Operating Income | $- | $1.32B | $996.71M | $911.17M | $895.36M |
Operating Income Ratio | 0.00% | 24.18% | 19.11% | 17.82% | 18.90% |
Total Other Income Expenses Net | $1.33B | $-122.72M | $-110.26M | $167.43M | $-101.23M |
Income Before Tax | $1.33B | $1.19B | $906.31M | $912.39M | $896.68M |
Income Before Tax Ratio | 22.96% | 21.92% | 17.38% | 17.84% | 18.93% |
Income Tax Expense | $255.88M | $223.51M | $166.61M | $167.43M | $164.91M |
Net Income | $1.07B | $970.75M | $894.39M | $744.96M | $731.77M |
Net Income Ratio | 18.53% | 17.82% | 17.15% | 14.57% | 15.45% |
EPS | $12.76 | $10.21 | $7.55 | $7.30 | $6.90 |
EPS Diluted | $12.63 | $10.07 | $7.47 | $7.22 | $6.82 |
Weighted Average Shares Outstanding | 83.95M | 95.08M | 97.93M | 102.07M | 106.08M |
Weighted Average Shares Outstanding Diluted | 84.75M | 96.36M | 98.98M | 103.17M | 107.22M |
SEC Filing | Source | Source | Source | Source | Source |
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $1.47B | $1.46B | $1.44B | $1.42B | $1.42B | $1.38B | $1.33B | $1.09B | $1.32B | $1.29B | $1.29B | $1.31B | $1.30B | $1.28B | $1.27B | $1.27B | $1.23B | $1.20B | $1.18B | $1.16B |
Cost of Revenue | $- | $104.87M | $99.11M | $93.21M | $91.76M | $85.87M | $86.03M | $- | $-937.32M | $88.14M | $89.66M | $84.35M | $-3.50B | $80.39M | $79.16M | $81.21M | $-3.21B | $75.40M | $72.71M | $78.58M |
Gross Profit | $1.47B | $1.35B | $1.34B | $1.32B | $1.32B | $1.30B | $1.24B | $1.09B | $2.26B | $1.20B | $1.20B | $1.22B | $4.80B | $1.20B | $1.19B | $1.19B | $4.44B | $1.12B | $1.11B | $1.09B |
Gross Profit Ratio | 100.00% | 92.80% | 93.10% | 93.40% | 93.50% | 93.80% | 93.50% | 100.00% | 170.90% | 93.20% | 93.10% | 93.60% | 370.00% | 93.70% | 93.80% | 93.60% | 361.08% | 93.69% | 93.84% | 93.25% |
Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
General and Administrative Expenses | $97.12M | $- | $- | $89.68M | $85.21M | $- | $- | $81.59M | $87.08M | $- | $- | $81.60M | $75.89M | $- | $- | $74.06M | $71.99M | $72.39M | $70.20M | $72.98M |
Selling and Marketing Expenses | $- | $- | $- | $- | $19.20M | $- | $- | $- | $9.40M | $- | $- | $- | $10.00M | $- | $- | $- | $9.80M | $- | $- | $- |
Selling General and Administrative Expenses | $97.12M | $- | $10.09M | $89.68M | $85.21M | $7.57M | $7.49M | $81.59M | $87.08M | $9.12M | $8.45M | $81.60M | $75.89M | $7.78M | $8.36M | $74.06M | $71.99M | $72.39M | $70.20M | $72.98M |
Other Expenses | $1.37B | $1.46B | $-201.02M | $-186.71M | $-189.30M | $-1.07B | $-1.06B | $1.01B | $-177.80M | $88.14M | $-236.85M | $-1.17B | $4.12B | $-945.77M | $-924.94M | $-1.02B | $2.07B | $- | $875.80M | $836.02M |
Operating Expenses | $1.47B | $1.46B | $201.02M | $186.71M | $189.30M | $-1.07B | $-1.06B | $1.09B | $-177.80M | $88.14M | $993.49M | $-1.09B | $4.05B | $-945.77M | $-924.94M | $-945.38M | $1.85B | $930.70M | $946.00M | $909.00M |
Cost and Expenses | $1.47B | $1.46B | $-1.09B | $-1.07B | $-1.05B | $1.07B | $1.06B | $1.09B | $1.06B | $1.06B | $1.02B | $1.11B | $1.08B | $1.05B | $1.03B | $1.05B | $978.96M | $963.50M | $968.64M | $961.99M |
Interest Income | $19.00K | $- | $- | $28.62M | $- | $25.95M | $25.82M | $- | $24.66M | $23.96M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Interest Expense | $35.70M | $31.39M | $31.40M | $28.62M | $25.68M | $25.95M | $25.82M | $24.87M | $24.66M | $23.96M | $21.83M | $19.94M | $19.65M | $20.89M | $21.77M | $21.18M | $21.41M | $21.67M | $22.81M | $20.81M |
Depreciation and Amortization | $- | $- | $-353.73M | $-343.54M | $-363.29M | $-344.77M | $-290.32M | $- | $-322.45M | $-260.16M | $-298.28M | $-314.12M | $-240.26M | $-251.68M | $-267.27M | $-244.80M | $-271.39M | $-253.21M | $-235.05M | $-227.00M |
EBITDA | $- | $408.35M | $- | $- | $- | $- | $- | $- | $282.38M | $- | $- | $- | $237.21M | $- | $- | $- | $271.39M | $253.21M | $235.05M | $223.73M |
EBITDA Ratio | 0.00% | 28.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 21.35% | 24.22% | -1.69% | 0.00% | 18.28% | 19.70% | 21.01% | 18.95% | 22.08% | 21.19% | 19.90% | 19.21% |
Operating Income | $- | $408.35M | $1.24B | $343.54M | $1.23B | $318.76M | $264.42M | $- | $2.44B | $253.95M | $298.28M | $221.56M | $237.21M | $251.68M | $267.01M | $239.97M | $731.77M | $188.94M | $173.05M | $165.54M |
Operating Income Ratio | 0.00% | 28.06% | 86.04% | 24.26% | 86.63% | 23.03% | 19.94% | 0.00% | 184.31% | 19.67% | 23.09% | 16.93% | 18.28% | 19.70% | 21.01% | 18.95% | 59.55% | 15.81% | 14.65% | 14.21% |
Total Other Income Expenses Net | $312.43M | $-31.39M | $-41.98M | $-34.53M | $1.22B | $-30.99M | $-28.79M | $274.23M | $-2.18B | $-32.31M | $-1.01B | $-116.26M | $-527.40M | $-26.67M | $-26.55M | $-28.84M | $-481.79M | $42.59M | $39.19M | $37.38M |
Income Before Tax | $312.43M | $376.96M | $322.32M | $314.92M | $336.71M | $318.81M | $264.51M | $274.23M | $257.72M | $229.98M | $276.45M | $201.62M | $217.56M | $230.79M | $245.24M | $218.79M | $249.98M | $231.54M | $212.24M | $202.92M |
Income Before Tax Ratio | 21.31% | 25.90% | 22.38% | 22.24% | 23.78% | 23.03% | 19.94% | 25.08% | 19.48% | 17.81% | 21.40% | 15.41% | 16.77% | 18.06% | 19.29% | 17.27% | 20.34% | 19.37% | 17.97% | 17.42% |
Income Tax Expense | $57.24M | $73.96M | $63.97M | $60.71M | $61.91M | $61.73M | $49.25M | $50.62M | $46.16M | $43.20M | $52.48M | $37.25M | $39.60M | $41.92M | $45.62M | $40.28M | $45.74M | $42.59M | $39.19M | $37.38M |
Net Income | $255.20M | $302.99M | $258.36M | $254.22M | $274.80M | $257.08M | $215.26M | $223.61M | $211.56M | $190.59M | $223.97M | $164.36M | $177.95M | $188.87M | $199.62M | $178.52M | $204.24M | $188.94M | $173.05M | $165.54M |
Net Income Ratio | 17.40% | 20.82% | 17.94% | 17.95% | 19.41% | 18.57% | 16.23% | 20.45% | 15.99% | 14.76% | 17.34% | 12.56% | 13.72% | 14.78% | 15.70% | 14.09% | 16.62% | 15.81% | 14.65% | 14.21% |
EPS | $3.04 | $3.45 | $2.75 | $2.71 | $2.88 | $2.72 | $2.26 | $2.32 | $2.18 | $1.92 | $2.28 | $1.66 | $1.77 | $1.86 | $1.94 | $1.73 | $1.96 | $1.78 | $1.63 | $1.54 |
EPS Diluted | $3.01 | $3.44 | $2.75 | $2.67 | $2.88 | $2.68 | $2.24 | $2.28 | $2.14 | $1.90 | $2.26 | $1.64 | $1.76 | $1.84 | $1.92 | $1.70 | $1.93 | $1.76 | $1.62 | $1.52 |
Weighted Average Shares Outstanding | 83.95M | 87.87M | 93.87M | 93.87M | 94.11M | 94.64M | 95.33M | 96.39M | 97.05M | 97.26M | 98.22M | 99.27M | 100.54M | 101.50M | 102.90M | 103.48M | 104.20M | 106.15M | 106.44M | 107.29M |
Weighted Average Shares Outstanding Diluted | 84.75M | 88.09M | 93.87M | 95.11M | 95.46M | 95.82M | 96.25M | 97.91M | 98.64M | 98.15M | 98.94M | 100.25M | 101.34M | 102.38M | 104.23M | 104.84M | 105.78M | 107.05M | 107.13M | 109.13M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Cash and Cash Equivalents | $165.32M | $103.16M | $92.56M | $92.16M | $94.85M |
Short Term Investments | $85.03M | $191.56M | $16.62B | $21.37B | $21.32B |
Cash and Short Term Investments | $250.36M | $103.16M | $16.71B | $21.47B | $21.42B |
Net Receivables | $691.91M | $630.22M | $- | $487.44M | $474.18M |
Inventory | $- | $- | $-18.10B | $-999.82M | $-998.20M |
Other Current Assets | $- | $- | $- | $- | $- |
Total Current Assets | $942.27M | $733.38M | $206.68M | $21.95B | $21.89B |
Property Plant Equipment Net | $- | $240.00M | $212.00M | $205.00M | $186.00M |
Goodwill | $490.45M | $481.79M | $481.79M | $481.79M | $441.59M |
Intangible Assets | $- | $- | $481.79M | $481.79M | $441.59M |
Goodwill and Intangible Assets | $490.45M | $481.79M | $481.79M | $481.79M | $441.59M |
Long Term Investments | $19.49B | $1.10B | $16.62B | $21.37B | $21.32B |
Tax Assets | $- | $1.09B | $686.17M | $1.77B | $1.83B |
Other Non-Current Assets | $-18.76B | $23.94B | $-17.52B | $-1.77B | $-1.83B |
Total Non-Current Assets | $1.22B | $26.86B | $481.79M | $22.06B | $21.95B |
Other Assets | $26.91B | $461.95M | $24.85B | $-14.25B | $-14.79B |
Total Assets | $29.08B | $28.05B | $25.54B | $29.77B | $29.05B |
Account Payables | $532.83M | $514.88M | $509.36M | $412.94M | $399.51M |
Short Term Debt | $415.40M | $486.11M | $449.10M | $479.64M | $254.92M |
Tax Payables | $731.25M | $494.64M | $686.17M | $1.77B | $1.83B |
Deferred Revenue | $- | $- | $686.17M | $66.70M | $-144.59M |
Other Current Liabilities | $-1.26B | $- | $-1.64B | $-2.66B | $-2.49B |
Total Current Liabilities | $415.40M | $1.50B | $1.14B | $479.64M | $254.92M |
Long Term Debt | $- | $1.63B | $1.63B | $1.55B | $1.67B |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $19.30B | $20.44B | $19.02B | $16.92B | $16.12B |
Total Non-Current Liabilities | $19.30B | $22.07B | $16.20B | $1.55B | $1.67B |
Other Liabilities | $4.05B | $- | $3.31B | $19.10B | $18.35B |
Total Liabilities | $23.77B | $23.56B | $20.64B | $21.13B | $20.28B |
Preferred Stock | $- | $- | $- | $- | $- |
Common Stock | $97.22M | $102.22M | $105.22M | $109.22M | $113.22M |
Retained Earnings | $8.00B | $7.48B | $6.47B | $6.18B | $5.87B |
Accumulated Other Comprehensive Income Loss | $-2.03B | $-2.77B | $-1.42B | $2.68B | $3.03B |
Other Total Stockholders Equity | $-764.50M | $-321.81M | $-259.86M | $-326.10M | $-245.48M |
Total Stockholders Equity | $5.31B | $4.49B | $4.90B | $8.64B | $8.77B |
Total Equity | $5.31B | $4.49B | $4.90B | $8.64B | $8.77B |
Total Liabilities and Stockholders Equity | $29.08B | $28.05B | $25.54B | $29.77B | $29.05B |
Minority Interest | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $29.08B | $28.05B | $25.54B | $29.77B | $29.05B |
Total Investments | $19.57B | $1.29B | $18.21B | $22.76B | $22.45B |
Total Debt | $415.40M | $2.12B | $2.08B | $2.03B | $1.92B |
Net Debt | $250.08M | $2.01B | $1.98B | $1.93B | $1.83B |
Balance Sheet Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $165.32M | $134.55M | $87.91M | $83.55M | $103.16M | $85.55M | $75.01M | $172.11M | $92.56M | $85.59M | $172.26M | $127.63M | $92.16M | $96.33M | $138.07M | $81.50M | $94.85M | $80.10M | $114.03M | $90.37M |
Short Term Investments | $17.24B | $100.50M | $228.96M | $144.93M | $191.56M | $16.34B | $17.10B | $17.28B | $16.62B | $16.09B | $17.30B | $19.24B | $21.37B | $21.25B | $21.47B | $20.25B | $21.32B | $20.54B | $20.19B | $18.15B |
Cash and Short Term Investments | $17.41B | $235.05M | $17.80B | $18.29B | $18.06B | $16.43B | $17.18B | $17.45B | $16.71B | $16.18B | $17.47B | $19.36B | $21.47B | $21.35B | $21.61B | $20.33B | $21.42B | $20.62B | $20.31B | $18.24B |
Net Receivables | $691.91M | $651.87M | $648.07M | $645.97M | $630.22M | $616.88M | $601.79M | $594.42M | $- | $475.36M | $478.57M | $487.93M | $487.44M | $485.48M | $484.39M | $477.60M | $474.18M | $458.36M | $445.54M | $441.74M |
Inventory | $- | $- | $-836.54M | $-18.93B | $-18.69B | $-17.49B | $-18.22B | $- | $-18.10B | $-16.26B | $-18.93B | $-19.40B | $-999.82M | $-22.21B | $-22.45B | $- | $- | $- | $- | $- |
Other Current Assets | $-18.10B | $- | $- | $- | $- | $- | $- | $-18.05B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Current Assets | $- | $886.92M | $1.24B | $1.17B | $1.20B | $786.36M | $747.93M | $42.50B | $206.68M | $1.47B | $172.26M | $1.51B | $21.95B | $675.16M | $994.39M | $81.50M | $22.55M | $80.10M | $114.03M | $90.37M |
Property Plant Equipment Net | $285.00M | $- | $-1.74B | $172.20M | $239.90M | $1.61B | $1.57B | $- | $212.00M | $- | $-856.10M | $-1.30B | $205.00M | $- | $- | $-1.59B | $186.00M | $-1.68B | $-1.63B | $-1.30B |
Goodwill | $490.45M | $490.45M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $441.59M | $441.59M | $441.59M | $441.59M | $441.59M | $441.59M |
Intangible Assets | $- | $- | $6.26B | $6.13B | $6.01B | $481.79M | $481.79M | $- | $481.79M | $481.79M | $5.08B | $5.00B | $4.91B | $4.84B | $4.74B | $441.59M | $4.60B | $4.52B | $4.45B | $4.39B |
Goodwill and Intangible Assets | $490.45M | $490.45M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $481.79M | $441.59M | $441.59M | $441.59M | $441.59M | $441.59M | $441.59M |
Long Term Investments | $17.24B | $20.63B | $17.71B | $18.20B | $1.10B | $16.34B | $17.10B | $1.65B | $16.62B | $16.09B | $17.30B | $19.24B | $21.37B | $21.25B | $21.47B | $20.25B | $21.32B | $20.54B | $20.19B | $18.15B |
Tax Assets | $- | $619.97M | $684.54M | $630.27M | $17.80B | $554.85M | $404.48M | $- | $- | $568.28M | $856.10M | $1.30B | $-5.73B | $1.75B | $1.77B | $1.59B | $-23.73B | $1.68B | $1.63B | $1.30B |
Other Non-Current Assets | $-18.02B | $- | $9.91B | $7.91B | $7.24B | $-17.95B | $-18.68B | $-2.13B | $-16.83B | $-16.66B | $8.09B | $-19.24B | $5.73B | $-21.25B | $-21.47B | $-20.25B | $23.73B | $-20.54B | $6.00B | $6.14B |
Total Non-Current Assets | $- | $21.74B | $27.06B | $27.40B | $26.86B | $1.04B | $886.27M | $-15.64B | $481.79M | $481.79M | $25.87B | $481.79M | $22.06B | $2.23B | $2.22B | $441.59M | $21.95B | $441.59M | $26.64B | $24.73B |
Other Assets | $29.08B | $6.93B | $- | $- | $- | $24.34B | $25.07B | $26.86B | $24.85B | $22.89B | $- | $25.86B | $-14.25B | $26.59B | $26.37B | $27.59B | $7.08B | $27.52B | $783.25M | $531.04M |
Total Assets | $29.08B | $29.56B | $28.30B | $28.57B | $28.05B | $26.17B | $26.71B | $26.86B | $25.54B | $24.84B | $26.04B | $27.85B | $29.77B | $29.50B | $29.58B | $28.11B | $29.05B | $28.04B | $27.53B | $25.35B |
Account Payables | $532.83M | $530.40M | $526.13M | $520.09M | $514.88M | $503.07M | $510.93M | $489.30M | $509.36M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Short Term Debt | $415.40M | $437.42M | $654.61M | $733.54M | $486.11M | $447.54M | $258.23M | $514.25M | $449.10M | $434.74M | $495.13M | $522.08M | $479.64M | $393.59M | $259.95M | $274.92M | $254.92M | $279.76M | $831.08M | $458.13M |
Tax Payables | $731.25M | $619.97M | $684.54M | $630.27M | $494.64M | $554.85M | $404.48M | $427.61M | $686.17M | $568.28M | $856.10M | $1.30B | $1.77B | $1.75B | $1.77B | $1.59B | $1.83B | $1.68B | $1.63B | $1.30B |
Deferred Revenue | $- | $- | $158.42M | $-520.09M | $-514.88M | $-1.01B | $-1.02B | $- | $686.17M | $568.28M | $- | $- | $1.77B | $- | $- | $- | $1.83B | $- | $- | $- |
Other Current Liabilities | $-1.68B | $-1.15B | $-1.87B | $-1.88B | $-1.50B | $-1.51B | $-1.17B | $-1.43B | $-765.50M | $-1.00B | $-1.35B | $-1.82B | $-2.24B | $-2.14B | $-2.03B | $-1.86B | $-2.09B | $- | $-2.46B | $-1.75B |
Total Current Liabilities | $- | $437.42M | $1.87B | $1.88B | $1.50B | $447.54M | $258.23M | $- | $1.14B | $434.74M | $495.13M | $522.08M | $479.64M | $393.59M | $259.95M | $1.86B | $254.92K | $1.96B | $18.41B | $17.48B |
Long Term Debt | $2.32B | $2.32B | $1.63B | $1.63B | $1.63B | $1.80B | $1.80B | $1.63B | $1.63B | $1.63B | $1.63B | $1.55B | $1.55B | $1.55B | $1.99B | $1.67B | $1.67B | $1.67B | $1.27B | $1.35B |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $568.28M | $- | $1.30B | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $-2.32B | $18.32B | $19.58B | $20.02B | $20.44B | $18.24B | $19.76B | $-1.63B | $20.41B | $18.85B | $17.31B | $19.41B | $16.92B | $16.80B | $18.98B | $16.35B | $16.12B | $15.82B | $15.57B | $15.37B |
Total Non-Current Liabilities | $- | $20.64B | $21.21B | $21.65B | $22.07B | $17.75B | $19.45B | $- | $16.20B | $16.71B | $1.63B | $16.31B | $1.55B | $1.55B | $1.99B | $1.67B | $1.67M | $1.67B | $1.27B | $1.35B |
Other Liabilities | $23.77B | $3.84B | $- | $- | $- | $3.34B | $3.02B | $23.01B | $3.31B | $3.34B | $18.60B | $4.12B | $19.10B | $18.95B | $18.72B | $16.75B | $20.27B | $16.19B | $- | $- |
Total Liabilities | $23.77B | $24.92B | $23.07B | $23.53B | $23.56B | $21.54B | $22.73B | $23.01B | $20.64B | $20.48B | $20.72B | $20.96B | $21.13B | $20.89B | $20.96B | $20.28B | $20.28B | $19.82B | $19.69B | $18.83B |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Common Stock | $97.22M | $102.22M | $102.22M | $102.22M | $102.22M | $105.22M | $105.22M | $105.22M | $105.22M | $109.22M | $109.22M | $109.22M | $109.22M | $113.22M | $113.22M | $113.22M | $113.22M | $117.22M | $117.22M | $117.22M |
Retained Earnings | $8.00B | $8.23B | $7.94B | $7.71B | $7.48B | $7.52B | $7.29B | $7.09B | $6.47B | $6.63B | $6.47B | $6.32B | $6.18B | $6.35B | $6.19B | $6.02B | $5.87B | $6.00B | $5.84B | $5.69B |
Accumulated Other Comprehensive Income Loss | $-2.03B | $-2.48B | $-2.19B | $-2.47B | $-2.77B | $-2.46B | $-2.94B | $-2.96B | $-1.42B | $-1.81B | $-731.49M | $869.50M | $2.68B | $2.66B | $2.75B | $2.02B | $3.03B | $2.55B | $2.23B | $1.07B |
Other Total Stockholders Equity | $-764.50M | $-1.20B | $-628.26M | $-302.48M | $-321.81M | $-543.01M | $-466.82M | $-390.38M | $-259.86M | $-569.44M | $-524.57M | $-400.30M | $-326.10M | $-519.95M | $-432.54M | $-325.95M | $-245.48M | $-445.34M | $-339.67M | $-349.61M |
Total Stockholders Equity | $5.31B | $4.64B | $5.23B | $5.04B | $4.49B | $4.62B | $3.98B | $3.85B | $4.90B | $4.36B | $5.32B | $6.89B | $8.64B | $8.61B | $8.62B | $7.83B | $8.77B | $8.22B | $7.85B | $6.52B |
Total Equity | $5.31B | $4.64B | $5.23B | $5.04B | $4.49B | $4.62B | $3.98B | $3.85B | $4.90B | $4.36B | $5.32B | $6.89B | $8.64B | $8.61B | $8.62B | $7.83B | $8.77B | $8.22B | $7.85B | $6.52B |
Total Liabilities and Stockholders Equity | $29.08B | $29.56B | $28.30B | $28.57B | $28.05B | $26.17B | $26.71B | $26.86B | $25.54B | $24.84B | $26.04B | $27.85B | $29.77B | $29.50B | $29.58B | $28.11B | $29.05B | $28.04B | $27.53B | $25.35B |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $29.08B | $29.56B | $28.30B | $28.57B | $28.05B | $26.17B | $26.71B | $26.86B | $25.54B | $24.84B | $26.04B | $27.85B | $29.77B | $29.50B | $29.58B | $28.11B | $29.05B | $28.04B | $27.53B | $25.35B |
Total Investments | $19.57B | $20.73B | $228.96M | $144.93M | $1.29B | $18.04B | $18.75B | $18.93B | $18.21B | $17.60B | $18.79B | $20.72B | $22.76B | $22.57B | $22.75B | $21.45B | $22.45B | $21.62B | $21.20B | $19.11B |
Total Debt | $2.74B | $2.76B | $2.29B | $2.36B | $2.12B | $2.25B | $2.06B | $2.14B | $2.08B | $2.06B | $2.12B | $2.07B | $2.03B | $1.94B | $2.25B | $1.94B | $1.92B | $1.95B | $2.10B | $1.80B |
Net Debt | $2.57B | $2.63B | $2.20B | $2.28B | $2.01B | $2.16B | $1.98B | $1.97B | $1.98B | $1.98B | $1.95B | $1.94B | $1.93B | $1.84B | $2.11B | $1.86B | $1.83B | $1.87B | $1.99B | $1.71B |
Annual Cash Flow
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
---|---|---|---|---|---|
Net Income | $1.07B | $970.75M | $739.70M | $744.96M | $731.77M |
Depreciation and Amortization | $410.00M | $- | $624.41M | $603.84M | $575.77M |
Deferred Income Tax | $- | $- | $-35.65M | $-30.27M | $-35.89M |
Stock Based Compensation | $- | $- | $35.65M | $30.27M | $35.89M |
Change in Working Capital | $- | $815.01M | $915.53M | $944.83M | $920.90M |
Accounts Receivables | $- | $- | $- | $- | $- |
Inventory | $- | $- | $- | $- | $- |
Accounts Payables | $- | $- | $- | $- | $- |
Other Working Capital | $828.62M | $815.01M | $795.06M | $677.43M | $832.75M |
Other Non Cash Items | $-78.32M | $-303.35M | $-857.45M | $-855.95M | $-752.01M |
Net Cash Provided by Operating Activities | $1.40B | $1.48B | $1.42B | $1.44B | $1.48B |
Investments in Property Plant and Equipment | $-71.05M | $-49.55M | $-27.93M | $-38.24M | $-41.76M |
Acquisitions Net | $- | $- | $- | $-5.25M | $-8.89M |
Purchases of Investments | $- | $- | $-1.83B | $-1.32B | $-1.64B |
Sales Maturities of Investments | $- | $- | $935.54M | $502.63M | $511.99M |
Other Investing Activities | $-570.47M | $-876.60M | $-25.23M | $-56.70M | $-7.05M |
Net Cash Used for Investing Activities | $-641.52M | $-926.15M | $-943.01M | $-913.37M | $-1.18B |
Debt Repayment | $628.84M | $37.35M | $54.20M | $99.97M | $278.68M |
Common Stock Issued | $51.79M | $114.08M | $106.59M | $69.83M | $48.09M |
Common Stock Repurchased | $-1.00B | $-511.10M | $-454.64M | $-541.43M | $-443.87M |
Dividends Paid | $-85.48M | $-84.12M | $-80.55M | $-80.04M | $-78.19M |
Other Financing Activities | $-308.86M | $-97.70M | $-118.06M | $-71.92M | $-78.77M |
Net Cash Used Provided by Financing Activities | $-715.84M | $-541.49M | $-492.45M | $-523.60M | $-274.06M |
Effect of Forex Changes on Cash | $17.08M | $-4.19M | $13.67M | $-3.39M | $-1.73M |
Net Change in Cash | $62.17M | $10.60M | $396.00K | $-2.68M | $18.91M |
Cash at End of Period | $165.32M | $103.16M | $92.56M | $92.16M | $94.85M |
Cash at Beginning of Period | $103.16M | $92.56M | $92.16M | $94.85M | $75.93M |
Operating Cash Flow | $1.40B | $1.48B | $1.42B | $1.44B | $1.48B |
Capital Expenditure | $-71.05M | $-49.55M | $-27.93M | $-38.24M | $-41.76M |
Free Cash Flow | $1.33B | $1.43B | $1.39B | $1.40B | $1.43B |
Cash Flow Charts
Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $- | $-512.57M | $258.36M | $254.22M | $274.80M | $257.08M | $215.26M | $- | $398.34M | $186.78M | $223.97M | $164.36M | $177.95M | $188.87M | $199.62M | $178.52M | $204.24M | $188.94M | $173.05M | $165.54M |
Depreciation and Amortization | $- | $- | $- | $- | $21.00M | $- | $- | $- | $624.41M | $- | $- | $- | $603.84M | $- | $- | $- | $575.77M | $- | $- | $- |
Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $-9.05M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Stock Based Compensation | $- | $- | $10.09M | $9.27M | $8.00M | $7.57M | $7.49M | $- | $9.05M | $9.12M | $8.45M | $9.04M | $5.97M | $7.78M | $8.36M | $7.89M | $9.24M | $8.67M | $8.63M | $9.36M |
Change in Working Capital | $- | $- | $- | $- | $839.81M | $- | $- | $- | $-1.05B | $357.00M | $- | $- | $1.80B | $- | $- | $-1.80B | $1.90B | $16.42B | $-905.21M | $-19.98B |
Accounts Receivables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Inventory | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Accounts Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Working Capital | $- | $- | $- | $- | $839.81M | $- | $- | $- | $795.06M | $- | $- | $- | $1.80B | $- | $- | $-1.80B | $1.90B | $16.42B | $-905.21M | $-19.98B |
Other Non Cash Items | $336.93M | $853.16M | $115.76M | $96.59M | $116.59M | $22.24M | $104.06M | $477.33M | $399.45M | $-195.90M | $63.84M | $-164.36M | $-2.21B | $169.11M | $130.59M | $2.00B | $-2.29B | $-16.30B | $1.16B | $20.16B |
Net Cash Provided by Operating Activities | $336.93M | $340.59M | $374.12M | $350.81M | $391.40M | $286.89M | $326.81M | $477.33M | $371.81M | $357.00M | $296.26M | $397.13M | $377.66M | $357.98M | $330.21M | $371.83M | $397.82M | $309.31M | $425.75M | $343.55M |
Investments in Property Plant and Equipment | $-15.00M | $-29.31M | $-17.63M | $-9.11M | $-13.10M | $-10.82M | $-17.42M | $-8.21M | $-8.16M | $-6.14M | $-6.65M | $-6.98M | $-7.51M | $-7.00M | $-8.20M | $-15.53M | $-12.97M | $-8.64M | $-10.83M | $-9.32M |
Acquisitions Net | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-3.84M | $- | $- | $- | $-3.17M | $-1.67M | $-408.00K | $-3.64M |
Purchases of Investments | $-379.41M | $1.24B | $-393.98M | $-842.35M | $-597.63M | $-577.64M | $-401.84M | $-326.46M | $-379.72M | $-485.91M | $-470.74M | $-489.02M | $-385.96M | $-88.86M | $-470.04M | $-370.95M | $-263.32M | $-137.13M | $-718.87M | $-516.71M |
Sales Maturities of Investments | $599.65M | $-636.49M | $516.97M | $119.52M | $512.56M | $181.62M | $267.71M | $118.94M | $145.16M | $217.37M | $350.01M | $223.01M | $110.70M | $203.91M | $71.31M | $116.71M | $90.13M | $122.76M | $81.12M | $217.98M |
Other Investing Activities | $-23.87M | $-766.84M | $122.98M | $-722.83M | $-85.07M | $-10.99M | $-10.82M | $-32.03M | $-9.44M | $-8.24M | $-125.96M | $-2.32M | $2.50M | $-61.90M | $1.21M | $82.00K | $48.00K | $-7.12M | $5.00K | $13.00K |
Net Cash Used for Investing Activities | $181.37M | $-196.30M | $105.35M | $-731.94M | $-98.18M | $-417.83M | $-162.37M | $-247.77M | $-252.17M | $-282.92M | $-132.61M | $-275.32M | $-284.12M | $46.15M | $-405.72M | $-269.69M | $-189.27M | $-31.80M | $-648.98M | $-311.68M |
Debt Repayment | $-22.02M | $482.62M | $-79.07M | $247.30M | $-130.97M | $189.31M | $-86.75M | $65.07M | $14.29M | $-60.53M | $52.83M | $42.35M | $85.97M | $-316.02M | $- | $20.00M | $-24.84M | $-152.03M | $298.66M | $-1.88M |
Common Stock Issued | $16.93M | $5.09M | $- | $29.76M | $53.00M | $18.90M | $5.16M | $37.02M | $57.06M | $14.80M | $8.80M | $25.93M | $2.48M | $1.02M | $33.60M | $32.72M | $20.76M | $9.81M | $717.00K | $16.81M |
Common Stock Repurchased | $-51.66M | $-591.11M | $-335.87M | $-23.47M | $-145.17M | $-96.90M | $-89.75M | $-179.28M | $-119.19M | $-72.03M | $-143.94M | $-119.48M | $-148.06M | $-97.80M | $-162.86M | $-132.72M | $-147.22M | $-129.92M | $- | $-166.73M |
Dividends Paid | $-20.19M | $-21.61M | $-22.56M | $-21.12M | $-21.17M | $-21.38M | $-21.50M | $-20.07M | $-20.11M | $-20.23M | $-20.52M | $-19.69M | $-19.98M | $-20.18M | $-20.38M | $-19.51M | $-19.69M | $-19.96M | $-19.95M | $-18.59M |
Other Financing Activities | $-424.02M | $29.92M | $-39.24M | $124.47M | $-27.42M | $46.85M | $-61.95M | $-54.49M | $-46.71M | $-32.30M | $-19.97M | $-13.81M | $-16.01M | $-17.54M | $285.46M | $-13.81M | $-16.07M | $-16.94M | $-26.11M | $139.11M |
Net Cash Used Provided by Financing Activities | $-500.95M | $-95.10M | $-476.74M | $356.96M | $-271.73M | $136.78M | $-254.79M | $-151.74M | $-114.66M | $-170.29M | $-122.80M | $-84.70M | $-95.60M | $-450.51M | $135.82M | $-113.32M | $-187.06M | $-309.03M | $253.31M | $-31.27M |
Effect of Forex Changes on Cash | $13.43M | $-2.56M | $1.64M | $4.57M | $-3.88M | $4.71M | $-6.75M | $1.73M | $1.99M | $9.54M | $3.78M | $-1.64M | $-2.11M | $4.63M | $-3.75M | $-2.17M | $-6.74M | $-2.41M | $-6.41M | $13.83M |
Net Change in Cash | $30.78M | $46.63M | $4.37M | $-19.61M | $17.61M | $10.54M | $-97.10M | $79.55M | $6.97M | $-86.67M | $44.63M | $35.47M | $-4.16M | $-41.75M | $56.57M | $-13.34M | $14.75M | $-33.93M | $23.66M | $14.44M |
Cash at End of Period | $165.32M | $134.55M | $87.91M | $83.55M | $103.16M | $85.55M | $75.01M | $172.11M | $92.56M | $85.59M | $172.26M | $127.63M | $92.16M | $96.33M | $138.07M | $81.50M | $94.85M | $80.10M | $114.03M | $90.37M |
Cash at Beginning of Period | $134.55M | $87.91M | $83.55M | $103.16M | $85.55M | $75.01M | $172.11M | $92.56M | $85.59M | $172.26M | $127.63M | $92.16M | $96.33M | $138.07M | $81.50M | $94.85M | $80.10M | $114.03M | $90.37M | $75.93M |
Operating Cash Flow | $336.93M | $340.59M | $374.12M | $350.81M | $391.40M | $286.89M | $326.81M | $477.33M | $371.81M | $357.00M | $296.26M | $397.13M | $377.66M | $357.98M | $330.21M | $371.83M | $397.82M | $309.31M | $425.75M | $343.55M |
Capital Expenditure | $-15.00M | $-29.31M | $-17.63M | $-9.11M | $-13.10M | $-10.82M | $-17.42M | $-8.21M | $-8.16M | $-6.14M | $-6.65M | $-6.98M | $-7.51M | $-7.00M | $-8.20M | $-15.53M | $-12.97M | $-8.64M | $-10.83M | $-9.32M |
Free Cash Flow | $321.93M | $311.28M | $356.49M | $341.70M | $378.29M | $276.07M | $309.39M | $469.12M | $363.64M | $350.86M | $289.61M | $390.15M | $370.14M | $350.98M | $322.01M | $356.30M | $384.85M | $300.67M | $414.92M | $334.24M |
Globe Life Dividends
Explore Globe Life's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
0.91%
Dividend Payout Ratio
7.98%
Dividend Paid & Capex Coverage Ratio
8.96x
Globe Life Dividend History
Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|
$0.27 | $0.27 | April 03, 2025 | April 03, 2025 | May 01, 2025 | February 27, 2025 |
$0.24 | $0.24 | January 06, 2025 | January 06, 2025 | January 31, 2025 | November 15, 2024 |
$0.24 | $0.24 | October 04, 2024 | October 04, 2024 | November 01, 2024 | August 08, 2024 |
$0.24 | $0.24 | July 05, 2024 | July 05, 2024 | August 01, 2024 | May 06, 2024 |
$0.24 | $0.24 | April 04, 2024 | April 05, 2024 | May 01, 2024 | March 18, 2024 |
$0.225 | $0.225 | October 05, 2023 | October 06, 2023 | November 01, 2023 | September 12, 2023 |
$0.225 | $0.225 | July 03, 2023 | July 05, 2023 | August 01, 2023 | June 21, 2023 |
$0.225 | $0.225 | March 31, 2023 | April 03, 2023 | May 01, 2023 | February 23, 2023 |
$0.2075 | $0.2075 | January 05, 2023 | January 06, 2023 | February 01, 2023 | December 13, 2022 |
$0.207 | $0.2075 | October 06, 2022 | October 07, 2022 | November 01, 2022 | September 07, 2022 |
$0.207 | $0.2075 | July 01, 2022 | July 05, 2022 | August 01, 2022 | May 17, 2022 |
$0.2075 | $0.2075 | April 01, 2022 | April 04, 2022 | April 29, 2022 | March 08, 2022 |
$0.198 | $0.1975 | January 06, 2022 | January 07, 2022 | February 01, 2022 | November 04, 2021 |
$0.198 | $0.1975 | October 01, 2021 | October 04, 2021 | November 01, 2021 | August 23, 2021 |
$0.198 | $0.1975 | July 01, 2021 | July 05, 2021 | July 30, 2021 | May 03, 2021 |
$0.198 | $0.1975 | April 01, 2021 | April 05, 2021 | April 30, 2021 | March 26, 2021 |
$0.1875 | $0.1875 | January 07, 2021 | January 08, 2021 | February 01, 2021 | December 21, 2020 |
$0.188 | $0.1875 | October 02, 2020 | October 05, 2020 | October 30, 2020 | August 21, 2020 |
$0.1875 | $0.1875 | July 02, 2020 | July 06, 2020 | July 31, 2020 | May 15, 2020 |
$0.1875 | $0.1875 | April 02, 2020 | April 03, 2020 | May 01, 2020 | March 05, 2020 |
Globe Life News
Read the latest news about Globe Life, including recent articles, headlines, and updates.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Globe Life Inc. (GL) And Encourages Shareholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Is Globe Life (GL) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Globe Life Inc. (GL) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

21 Upcoming Dividend Increases To Finish Q1
The lists were created using the U.S. Dividend Champions spreadsheet and NASDAQ data, ensuring companies have at least five years of dividend growth. My investment strategy focuses on buying, holding, and adding to companies with consistent dividend growth and outperformance relevant to certain benchmarks. Top-performing stocks include MPWR, STLD, and JPM. Top REITs include CTR, FR, and REXR for their impressive returns and dividend growth rates.

Bronstein, Gewirtz & Grossman, LLC Encourages Globe Life Inc. (GL) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Globe Life Inc. (GL) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Globe Life Inc. (GL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Is Globe Life (GL) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Globe Life Inc. (GL) And Encourages Stockholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / March 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Globe Life Inc. (GL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Globe Life Inc. (GL) and Encourages Stockholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Bronstein, Gewirtz & Grossman, LLC Encourages Globe Life Inc. (GL) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
MCKINNEY, Texas , Feb. 27, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has raised the quarterly dividend to $.2700 per share on all of the outstanding common stock of the Company held of record as of close of business of the Company's transfer agent on April 3, 2025. The dividend will be paid on May 1, 2025.

Should Value Investors Buy Globe Life (GL) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Globe Life Inc. (NYSE: GL) and Encourages Long-Term Globe Life Investors to Contact the Firm
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Globe Life Inc. (NYSE: GL), formerly known as Torchmark Corp., on behalf of the company's long-term shareholders. Click here for additional information: https://kaskelalaw.com/case/globe-life/ Recently a securities fraud complaint was filed against Globe Life on behalf of investors who purchased shares of the company's stock between May 8, 2019 and April 10, 2024.

Globe Life Inc. (GL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Bronstein, Gewirtz & Grossman, LLC Encourages Globe Life Inc. (GL) Shareholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Globe Life Pledges $2 Million to the National Medal of Honor Museum Foundation
New partnership underscores Globe Life and NMOHMF's shared commitment to those who have made the ultimate sacrifice MCKINNEY, Texas , Feb. 11, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) a Texas-based life insurance company, is pledging $2 million to the National Medal of Honor Museum Foundation (NMOHMF) ahead of the National Medal of Honor Museum's Grand Opening in Arlington, Texas, this coming spring. In recognition of this founding donation, the stage at the Museum's Neel Kearby Theater will bear the Globe Life name.

Are Investors Undervaluing Globe Life (GL) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Globe Life Inc. (GL) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / February 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globe Life Inc. ("Globe Life" or "the Company") (NYSE:GL). Investors who purchased Globe Life securities prior to May 8, 2019, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GL.

Globe Life Inc. (GL) Q4 2024 Earnings Call Transcript
Globe Life Inc. (NYSE:GL ) Q4 2024 Earnings Conference Call February 6, 2025 11:00 AM ET Company Participants Stephen Mota - Senior Director, Investor Relations Frank Svoboda - Co-Chief Executive Officer Matt Darden - Co-Chief Executive Officer Tom Kalmbach - Chief Financial Officer Conference Call Participants Jimmy Bhullar - JPMorgan Jack Matten - BMO Capital Markets Elyse Greenspan - Wells Fargo Wilma Burdis - Raymond James John Barnidge - Piper Sandler Wes Carmichael - Autonomous Research Andrew Kligerman - TD Securities Suneet Kamath - Jefferies Tom Gallagher - Evercore Operator Welcome to the Globe Life Fourth Quarter 2024 Earnings Release Conference Call. My name is Alan and I'll be your coordinator for today's event.

Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for GL.